Value of (18)F-FDG Hybrid PET/MR in Differentiated Thyroid Cancer Patients with Negative (131)I Whole-Body Scan and Elevated Thyroglobulin Levels

PURPOSE: To evaluate the diagnostic performance of (18)F-FDG PET/MR in detecting recurrent or metastatic disease in patients with differentiated thyroid cancer (DTC) who have increased thyroglobulin (Tg) levels but a negative (131)I whole-body scan (WBS). The relationship between (18)F-FDG PET/MR an...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Hongyan, Chen, Xiaomin, Zhang, Yajing, Wang, Kun, Gao, Zairong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018385/
https://www.ncbi.nlm.nih.gov/pubmed/33824601
http://dx.doi.org/10.2147/CMAR.S293005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018385/
https://www.ncbi.nlm.nih.gov/pubmed/33824601
http://dx.doi.org/10.2147/CMAR.S293005

Ejemplares similares